Comprehensive Stock Analysis of Athersys, Inc.(NASDAQ:ATHX): Amedisys Inc(NASDAQ:AMED)

0
9

Athersys, Inc. (ATHX) will report its next earnings on May 08 AMC. The company reported the earnings of $-0.09/Share in the last quarter where the estimated EPS by analysts was $-0.07/share. The difference between the expected and actual EPS was $-0.02/share, which represents an Earnings surprise of -28.6%.

Many analysts are providing their Estimated Earnings analysis for Athersys, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.08/share. These analysts have also projected a Low Estimate of $-0.09/share and a High Estimate of $-0.07/share.

In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for Athersys, Inc. as 3.08 Million. According to these analysts, the Low Revenue Estimate for Athersys, Inc. is 470 Million and the High Revenue Estimate is 5.68 Million. The company had Year Ago Sales of 19.39 Million.

Some buy side analysts are also providing their Analysis on Athersys, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Athersys, Inc. might touch $8 high while the Average Price Target and Low price Target is $7 and $6 respectively.

Athersys, Inc. closed its last trading session at $1.58 with the gain of 13.92%. The Market Capitalization of the company stands at 259.85 Million. The Company has 52-week high of $3.09 and 52-week low of $1.35. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 16.17% where SMA50 and SMA200 are 17.66% and 2.74% respectively. The Company Touched its 52-Week High on 06/07/18 and 52-Week Low on 04/18/19.

The Relative Volume of the company is 4.57 and Average Volume (3 months) is 591.55 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -41.7%. The Return on Equity (ROE) value stands at -58.1%. While it’s Return on Investment (ROI) value is -58.1%.

While looking at the Stock’s Performance, Athersys, Inc. currently shows a Weekly Performance of 12.5%, where Monthly Performance is 25%, Quarterly performance is 17.65%, 6 Months performance is -5.76% and yearly performance percentage is -13.46%. Year to Date performance value (YTD perf) value is 25%. The Stock currently has a Weekly Volatility of 8.66% and Monthly Volatility of 7.34%.

Amedisys Inc (AMED) will report its next earnings on Apr 30 AMC. The company reported the earnings of $1.11/Share in the last quarter where the estimated EPS by analysts was $0.9/share. The difference between the expected and actual EPS was $0.21/share, which represents an Earnings surprise of 23.3%.

Many analysts are providing their Estimated Earnings analysis for Amedisys Inc and for the current quarter 13 analysts have projected that the stock could give an Average Earnings estimate of $0.98/share. These analysts have also projected a Low Estimate of $0.9/share and a High Estimate of $1.11/share.

In case of Revenue Estimates, 13 analysts have provided their consensus Average Revenue Estimates for Amedisys Inc as 489.26 Million. According to these analysts, the Low Revenue Estimate for Amedisys Inc is 480.08 Million and the High Revenue Estimate is 497.14 Million. The company had Year Ago Sales of 413.29 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for AMED to be -3%. They are projecting Next Quarter growth of 2.11%. For the next 5 years, Amedisys Inc is expecting Growth of 13.39% per annum, whereas in the past 5 years the growth was 12.4% per annum.

Some buy side analysts are also providing their Analysis on Amedisys Inc, where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Amedisys Inc might touch $150 high while the Average Price Target and Low price Target is $136 and $120 respectively.

Amedisys Inc closed its last trading session at $112.52 with the loss of -1.57%. The Market Capitalization of the company stands at 3.57 Billion. The Company has 52-week high of $140.91 and 52-week low of $71.06. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -7.88% where SMA50 and SMA200 are -9.45% and -8.19% respectively. The Company Touched its 52-Week High on 12/04/18 and 52-Week Low on 05/17/18.

The Relative Volume of the company is 0.76 and Average Volume (3 months) is 548.48 million. The company’s P/E (price to earnings) ratio is 29.76 and Forward P/E ratio of 24.23.

The company shows its Return on Assets (ROA) value of 14.6%. The Return on Equity (ROE) value stands at 26.6%. While it’s Return on Investment (ROI) value is 23.6%.

While looking at the Stock’s Performance, Amedisys Inc currently shows a Weekly Performance of -5.86%, where Monthly Performance is -12.31%, Quarterly performance is -18.37%, 6 Months performance is -6.96% and yearly performance percentage is 54.23%. Year to Date performance value (YTD perf) value is -5.43%. The Stock currently has a Weekly Volatility of 2.91% and Monthly Volatility of 4.77%.

SHARE